AMERICAN CENTURY COMPANIES INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2016$1,592,000
-56.4%
135,063
-52.1%
0.00%
-50.0%
Q2 2016$3,649,000
-17.6%
281,966
+1.9%
0.00%
-20.0%
Q1 2016$4,426,000
+1083.4%
276,812
+2559.9%
0.01%
Q2 2015$374,000
-68.0%
10,407
-62.5%
0.00%
-100.0%
Q4 2014$1,169,000
-70.8%
27,725
-73.2%
0.00%
-80.0%
Q3 2014$4,007,000
+121.6%
103,317
+78.4%
0.01%
+150.0%
Q2 2014$1,808,00057,9030.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders